Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [11C]acetate PET as a prognostic marker

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.

(2017) Christopher Sweeney et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate Cancer

(2017) James Mohler et al.   Journal of the National Comprehensive Cancer Network

Novel Nuclear Localization of Fatty Acid Synthase Correlates with Prostate Cancer Aggressiveness

(2014) Allison A. Madigan et al.   AMERICAN JOURNAL OF PATHOLOGY

Combined PET/MRI Improves Diagnostic Accuracy in Patients with Prostate Cancer: A Prospective Diagnostic Trial

(2014) M. Hartenbach et al.   CLINICAL CANCER RESEARCH

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence

(2014) Reginald W. Dusing et al.   CLINICAL NUCLEAR MEDICINE

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

(2014) Ali Afshar-Oromieh et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Late Imaging with [1-11C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET

(2014) D. Y. Lewis et al.   JOURNAL OF NUCLEAR MEDICINE

Prognostic prostate tissue biomarkers of potential clinical use

(2014) Theodorus H. Van der Kwast   VIRCHOWS ARCHIV

18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients

(2013) Claudia Brogsitter et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction

(2013) M. Haseebuddin et al.   JOURNAL OF NUCLEAR MEDICINE

Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome

(2013) Yukie Yoshii et al.   PLoS One

11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation

(2012) E. Mena et al.   JOURNAL OF NUCLEAR MEDICINE

Development and experimental medicine applications of PET in oncology: a historical perspective

(2012) Terry Jones et al.   LANCET ONCOLOGY

Unusually Large Numbers Needed to Treat for Radical Prostatectomy in Prostate Cancer Patients with PSA Velocity =2 ng/ml/Year

(2012) J. Scheerer et al.   UROLOGIA INTERNATIONALIS

Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence

(2011) Stephen A. Boorjian et al.   EUROPEAN UROLOGY

Functional Imaging of Localized Prostate Cancer Aggressiveness Using 11C-Acetate PET/CT and 1H-MR Spectroscopy

(2010) I. Jambor et al.   JOURNAL OF NUCLEAR MEDICINE

68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors

(2010) A. R. Haug et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging Localized Prostate Cancer: Current Approaches and New Developments

(2009) Baris Turkbey et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: A systematic review and meta-analysis of randomised trials

(2009) M.D. Shelley et al.   CANCER TREATMENT REVIEWS

Diffuse FDG Uptake in Acute Prostatitis

(2009) Pan-Fu Kao et al.   CLINICAL NUCLEAR MEDICINE

Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer

(2009) Toshiro Migita et al.   JNCI-Journal of the National Cancer Institute

Normal organ standard uptake values in carbon-11 acetate PET imaging

(2009) Won S. Song et al.   NUCLEAR MEDICINE COMMUNICATIONS

1-11C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer

(2008) A. L. Vavere et al.   JOURNAL OF NUCLEAR MEDICINE